French pharmaceutical giant Sanofi is donating 100 million doses of a malaria drug being tested for use as a treatment against the new coronavirus.
The company said in a statement on Friday that the hydroxychloroquine doses will be given to 50 countries.
Sanofi is also ramping up production, aiming to quadruple is capacity to manufacture the drug.
The company said it “will continue to donate the medicine to governments and hospital institutions if ongoing clinical studies demonstrate its efficacy and safety in Covid-19 patients”.
But it also warned that hydroxychloroquine has “several serious known side-effects” and tests are so far inconclusive over its safety and efficacy in treating Covid-19.
“While hydroxychloroquine is generating a lot of hope for patients around the world, it should be remembered that there are no results from ongoing studies, and the results may be positive or negative,” it said.
US President Donald Trump has been among the drug’s proponents, tweeting that hydroxychloroquine plus an antibiotic could be “one of the biggest game changers in the history of medicine” and should “be put in use immediately”.
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here